RT Journal Article
SR Electronic
T1 Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006747
DO 10.1136/jitc-2023-006747
VO 11
IS 6
A1 Hamid, Omid
A1 Hassel, Jessica C
A1 Shoushtari, Alexander N
A1 Meier, Friedegund
A1 Bauer, Todd M
A1 Salama, April K S
A1 Kirkwood, John M
A1 Ascierto, Paolo A
A1 Lorigan, Paul C
A1 Mauch, Cornelia
A1 Orloff, Marlana
A1 Evans, Thomas R Jeffry
A1 Holland, Chris
A1 Edukulla, Ramakrishna
A1 Abedin, Shaad E
A1 Middleton, Mark R
YR 2023
UL http://jitc.bmj.com/content/11/6/e006747.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.